PTGS2 and obesity disorder: Consistently, many works have considered the contribution of COX-2-derived PGs in obesity development, and evaluated the benefit of pharmacological or genetic COX-2 inhibition on diet-induced obesity (Hsieh et al., 2010; Chan et al., 2016; Rossi et al., 2018).